Press "esc" to clear
Go to Advanced Search

Showing results

1120 of 32258
Embargo will expire:
25-Jul-2018 5:00 PM EDT
Released to reporters:
20-Jul-2018 10:05 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 25-Jul-2018 5:00 PM EDT

Embargo will expire:
24-Jul-2018 11:00 AM EDT
Released to reporters:
20-Jul-2018 9:05 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 24-Jul-2018 11:00 AM EDT

7-20-18Paige.jpg
  • Embargo expired:
    20-Jul-2018 5:00 AM EDT

Article ID: 697636

Drug Now in Clinical Trials for Parkinson’s Strengthens Heart Contractions in Animals

Johns Hopkins Medicine

A drug currently in clinical trials for treating symptoms of Parkinson’s disease may someday have value for treating heart failure, according to results of early animal studies by Johns Hopkins Medicine researchers.

Released:
19-Jul-2018 10:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Indianwomanwithoxygen.jpg
  • Embargo expired:
    20-Jul-2018 12:15 AM EDT

Article ID: 697581

Supplemental Oxygen Eliminates Morning Blood Pressure Rise in Sleep Apnea Patients Following CPAP Withdrawal

American Thoracic Society (ATS)

Supplemental oxygen eliminates the rise in morning blood pressure experienced by obstructive sleep apnea (OSA) patients who stop using continuous positive airway pressure (CPAP), the standard treatment for OSA, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.

Released:
18-Jul-2018 9:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Embargo will expire:
23-Jul-2018 3:00 PM EDT
Released to reporters:
19-Jul-2018 8:00 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 23-Jul-2018 3:00 PM EDT

Article ID: 697689

Two Faces Offer Limitless Possibilities

Argonne National Laboratory

Named for the mythical god with two faces, Janus membranes — double-sided membranes that serve as gatekeepers between two substances — have emerged as a material with potential industrial uses.

Released:
19-Jul-2018 6:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    19-Jul-2018 5:00 PM EDT

Article ID: 697392

Study Reveals Long-Term Effectiveness of Therapy for Common Cause of Kidney Failure

American Society of Nephrology (ASN)

• Among individuals with autosomal dominant polycystic kidney disease, those who were treated with tolvaptan for up to 11 years had a slower rate of kidney function decline compared with historical controls. • Annualized kidney function decline rates of tolvaptan-treated patients did not change during follow-up.

Released:
13-Jul-2018 9:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Embargo will expire:
25-Jul-2018 4:00 PM EDT
Released to reporters:
19-Jul-2018 4:35 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 25-Jul-2018 4:00 PM EDT

20170301_Ferrari_jsc_073.jpg

Article ID: 697683

Research: The More ‘Stuff’ You Have, the More Likely You Are to Be a Procrastinator

DePaul University

An overabundance of “stuff” can have a detrimental effect on a person’s mental health and disrupt their sense of home, says procrastination researcher Joseph Ferrari, a professor of psychology at DePaul University.

Released:
19-Jul-2018 4:30 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Social and Behavioral Sciences

Relaxor900x600.jpg

Article ID: 697682

Relax, Just Break It

Argonne National Laboratory

Argonne scientists and their collaborators are helping to answer long-held questions about a technologically important class of materials called relaxor ferroelectrics.

Released:
19-Jul-2018 4:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

1120 of 32258





Chat now!